Global Malaria Markets, Epidemiology and Patient Flow Report 2020-2035 - Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries - ResearchAndMarkets.com

b'The "Global Malaria Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Malaria Epidemiology and Patient Flow Analysis - 2021, provides Malaria epidemiology, demographics, and patient flow.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Friday, May 14, 2021
Information
Tags: 
Health, Other Health, Infectious diseases, Medical specialties, Tropical diseases, Malaria, Malaria Atlas Project, Mass drug administration
Geotags: 
JAPAN, US, FRANCE, SPAIN, ITALY, UK
⚠generated by AI ↴
Summary
Key Points: 
  • b'The "Global Malaria Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Malaria Epidemiology and Patient Flow Analysis - 2021, provides Malaria epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Malaria patients, history of the disease at the population level (Malaria prevalence, Malaria incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Malaria patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Malaria market sizing, assessing market potential, and developing drug forecast models\nIdentify Malaria patients segments through age groups, gender, and disease sub-types\n'


The "Global Malaria Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Malaria Epidemiology and Patient Flow Analysis - 2021, provides Malaria epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Malaria patients, history of the disease at the population level (Malaria prevalence, Malaria incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Malaria patient flow: Malaria prevalence, diagnosed, and drug-treated patients
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries
  • Demographics: Malaria patients by age group, gender
  • Forecast: Malaria epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Malaria market sizing, assessing market potential, and developing drug forecast models
  • Identify Malaria patients segments through age groups, gender, and disease sub-types
  • Develop Malaria population-based health management frameworks
  • Evaluate Malaria market opportunities, identify target patient population
  • Align marketing decisions with the Malaria target population
  • Communicate leadership and health authorities about your Malaria target patient population

Key Topics Covered:

1. Research Methodology

2. Malaria Patients Definition

3. US Malaria Epidemiology and Patient Flow

4. Germany Malaria Epidemiology and Patient Flow

5. France Malaria Epidemiology and Patient Flow

6. Italy Malaria Epidemiology and Patient Flow

7. Spain Malaria Epidemiology and Patient Flow

8. UK Malaria Epidemiology and Patient Flow

9. Europe Malaria Epidemiology and Patient Flow

10. Japan Malaria Epidemiology and Patient Flow

11. Global Malaria Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/3eunv4

Copyright: 
Copyright Business Wire 2021